Cardiac Performance in Pregnant Obese Women:Are They in Jeopardy?
NCT ID: NCT02436343
Last Updated: 2018-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2015-06-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.
NCT03638245
The Right Heart During and After Pregnancy - an Echocardiographic Study
NCT03402971
Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios
NCT05737043
Echocardiographic Assessment of Ventricular Strain During a Healthy Pregnancy in the First, Second, and Third Trimester.
NCT04395014
Prevalence of Hypovolemia and Heart Failure in Non-cardiac Surgery
NCT03349593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Obesity has reached particularly alarming levels in the Middle East and North Africa (MENA) region. The prevalence of female obesity currently estimated at over 40% , had already exceeded that in Europe and the USA.
Obesity has been linked to several major chronic diseases, including type II diabetes, cardiovascular diseases, selected cancers, gallbladder disease, asthma, osteoarthritis, and chronic back pain.
Obesity has been also linked to a wide spectrum of cardiovascular changes ranging from a hyper dynamic circulation, through subclinical cardiac structural changes, to overt heart failure.
Obesity is associated with hemodynamic overload due to the increased metabolic demand imposed by the expanded adipose tissue and augmented fat-free mass in obesity results in a hyper dynamic circulation with increased blood volume. In addition to the increased preload, left ventricular (LV) after load is also elevated in obese individuals due to both increased peripheral resistance and greater conduit artery stiffness. Right ventricular after load may be increased, presumably due to associated sleep disordered breathing and LV changes.
Pregnancy is associated with hemodynamic and hormonal changes that can affect the heart. From the first trimester, there is an increase in cardiac output that places a volume load on the heart. Hormonal changes include increased circulating estrogen and relaxin, which may directly or indirectly affect the heart. During pregnancy, the heart undergoes remodeling similar to that observed in athletes, with increases in chamber dimensions, left ventricular (LV) wall thickness, and mass, that is consistent with a process of eccentric hypertrophy.
Myocardial contractile function also changes in pregnancy. Ejection-phase indices of LV function, including systolic fractional shortening (FS) and mean velocity of circumferential fiber thickening (V CFC), have been variously reported to increase, remain constant,or decrease, during pregnancy. Thus, obese women are more likely to encounter problems on becoming pregnant.
There is large evidence in the literature demonstrating that women who are overweight are at greater risk of developing pregnancy complications and problems associated with labor and delivery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
obese pregnant women
pregnant women wit body mass index more than or equal to 30 kg/m2 will be subjected to four serial echocardiograms in the 3 trimesters of pregnancy and in the postpartum state.
Height, weight, systolic and diastolic blood pressures will be measured at each echocardiographic evaluation.
echocardiogram
At each echocardiographic evaluation, the investigator will obtain the following parameters:
Left ventricular internal dimensions at end diastole Left ventricular posterior wall thickness Left ventricular end systolic stress Left ventricular fractional shortening Velocity of circumferential shortening Left ventricular mass Contractility and indices of preload Stroke volume
lean pregnant women
pregnant women wit body mass index less than or equal to 25kg/m2 will be subjected to four serial echocardiograms in the 3 trimesters of pregnancy and in the postpartum state.
Height, weight, systolic and diastolic blood pressures will be measured at each echocardiographic evaluation.
echocardiogram
At each echocardiographic evaluation, the investigator will obtain the following parameters:
Left ventricular internal dimensions at end diastole Left ventricular posterior wall thickness Left ventricular end systolic stress Left ventricular fractional shortening Velocity of circumferential shortening Left ventricular mass Contractility and indices of preload Stroke volume
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
echocardiogram
At each echocardiographic evaluation, the investigator will obtain the following parameters:
Left ventricular internal dimensions at end diastole Left ventricular posterior wall thickness Left ventricular end systolic stress Left ventricular fractional shortening Velocity of circumferential shortening Left ventricular mass Contractility and indices of preload Stroke volume
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Anemia.
* Medical history of hypertension.
* Medical history of any cardiac disease.
* Medical history of pre-gestational diabetes.
* Development of gestational diabetes and pre-eclampsia.
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Armed Forces Hospitals, Southern Region, Saudi Arabia
OTHER_GOV
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ahmed abdulmoneim altraigey
lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed altraigey
Role: STUDY_DIRECTOR
Benha University
haytham attya
Role: PRINCIPAL_INVESTIGATOR
Zagazig University
nuzhat amer
Role: PRINCIPAL_INVESTIGATOR
Armed Forces Hospitals, Southern Region, Saudi Arabia
Mohamed Kolkailah
Role: STUDY_CHAIR
Armed Forces Hospitals, Southern Region, Saudi Arabia
mohammed mesilhy
Role: PRINCIPAL_INVESTIGATOR
Armed Forces Hospitals, Southern Region, Saudi Arabia
mohammed attia
Role: PRINCIPAL_INVESTIGATOR
Armed Forces Hospitals, Southern Region, Saudi Arabia
mohammed shehri
Role: PRINCIPAL_INVESTIGATOR
Armed Forces Hospitals, Southern Region, Saudi Arabia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
antenatal clinic of Armed Forces Hospital, Southern Region
Khamis Mushait, 'Asir Region, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AFHSRMREC/2015/OB/GYNAE/061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.